Citation Impact
Citing Papers
Effects of Verum Acupuncture Compared to Placebo Acupuncture on Quantitative EEG and Heart Rate Variability in Healthy Volunteers
2008
Antidepressant Drug Effects and Depression Severity
2010 Standout
The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
2012 Standout
Pharmacological studies on the sedative and hypnotic effect of Kava kava and Passiflora extracts combination
2004
Haloperidol dose for the acute phase of schizophrenia
2002
The evolution of human skin coloration
2000 Standout
Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social–separation–stress procedure
2003
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
2005 Standout
Synthesis of enantiopure chloroalcohols by enzymatic kinetic resolution
2006 StandoutNobel
Stress‐induced insomnia treated with kava and valerian: singly and in combination
2001
How to perform a meta-analysis with R: a practical tutorial
2019 Standout
Twelve-Month Use of Mental Health Services in the United States
2005 Standout
Herb-drug interactions
2000 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Does a Placebo Run-In or a Placebo Treatment Cell Affect the Efficacy of Antidepressant Medications?
1994
Flaviviruses are neurotropic, but how do they invade the CNS?
2014
Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
2008 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Kava-kava and anxiety: Growing knowledge about the efficacy and safety
2002
Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials
2002
A meta-analysis of antidepressant outcome under "blinder" conditions.
1992
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
2005 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia
2006
Medicinal plants: Traditions of yesterday and drugs of tomorrow
2005 Standout
Efficacy of Kava Extract for Treating Anxiety: Systematic Review and Meta-Analysis
2000
Therapeutic Potential of Kava in the Treatment of Anxiety Disorders
2002
The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States
2001 Standout
Herbal Remedies in Psychiatric Practice
1998
Stress signalling pathways that impair prefrontal cortex structure and function
2009 Standout
Dose Response and Dose Equivalence of Antipsychotics
2004
Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study
2010 Standout
A Systematic Review of the Safety of Kava Extract in the Treatment of Anxiety
2002
Validity of Clinical Trials of Antidepressants
2000
Meta-analysis of the efficacy of the acetonic kava-kava extract WS®1490 in patients with non-psychotic anxiety disorders
2005
Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines
2001
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
Haloperidol versus placebo for schizophrenia
2001
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement
2010 Standout
Study of Health in Pomerania (SHIP): A health examination survey in an east German region: Objectives and design
2001 Standout
Herb-Drug Interactions
2005 Standout
Synergy and other interactions in phytomedicines
2001 Standout
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
2014 Standout
An Internet-Based Randomized, Placebo-Controlled Trial of Kava and Valerian for Anxiety and Insomnia
2005
Herbal Medicines and Perioperative Care
2001 Standout
The α1-Adrenergic Antagonist Prazosin Improves Sleep and Nightmares in Civilian Trauma Posttraumatic Stress Disorder
2002
Dietary Supplements and Natural Products as Psychotherapeutic Agents
1999
West Nile virus
2002
Behavioural treatments for non-epileptic attack disorder
2007
Woodsmoke Health Effects: A Review
2006 Standout
Interactions Between Herbal Medicines and Prescribed Drugs
2001 Standout
Plants and the central nervous system
2003 Standout
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
WPA guidance on how to combat stigmatization of psychiatry and psychiatrists
2010
Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type
1992
A Meta-analysis of the Efficacy of Second-Generation Antipsychotics
2003
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Potential medicinal plants for CNS disorders: an overview
2006
Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP
1997 Standout
III. Physical characteristics of Yemenite and Kurdish Jews in Israel
1973
Alzheimer's disease
2017 Standout
The clinical global impressions scale: applying a research tool in clinical practice.
2007 Standout
The Impact of Mental Illness Stigma on Seeking and Participating in Mental Health Care
2014 Standout
Risperidone versus typical antipsychotic medication for schizophrenia
2003
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
1997
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia
2005
Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats
1998
Haloperidol dose for the acute phase of schizophrenia
2013
Chemoenzymatic synthesis of duloxetine and its enantiomer: lipase-catalyzed resolution of 3-hydroxy-3-(2-thienyl) propanenitrile
2003
Operational criteria and factors related to recovery from schizophrenia
2002
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Haloperidol versus placebo for schizophrenia
2013
Kava extract versus placebo for treating anxiety
2003
Biomass burning — a review of organic tracers for smoke from incomplete combustion
2002 Standout
Antidepressants for treating depression in dementia
2002
The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna
2015 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
2010
Industry sponsorship and research outcome
2017 Standout
Identification and emission factors of molecular tracers in organic aerosols from biomass burning Part 1. Temperate climate conifers
2001
Identification and emission factors of molecular tracers in organic aerosols from biomass burning Part 2. Deciduous trees
2001
Alternative medicine: Herbal drugs and their critical appraisal - Part II
2001
Works of E. Lehmann being referenced
Experimental comparison between the effect of standardized trazodone-amitriptyline and placebo treatment in vitalized depressive patients
1988
Experimental Examination of Trazodone
1989
Beeinflusst Akupunktur die autonom kardiale Regulation bei Patienten mit leichten depressiven Episoden oder Angststörungen?
2003
Fluoxetine in Patients with Major Depressive Disorder - A Responder Analysis
1995
Zur Streitfrage der standardisierten Haloperidolbehandlungen im Vergleich zur ,,adäquaten individuellen Dosierung" bei akut erkrankten schizophrenen Patienten
1992
Confirmed Clinical Efficacy of Actovegin®in Elderly Patients with Organic Brain Syndrome
1995
Einstellungen von Studierenden der Medizin zur Psychiatrie
2000
Initial Improvement as a Criterion for Drug Choice in Acute Schizophrenia
1993
The Efficacy of Cavain in Patients Suffering from Anxiety
1989
Doppelblindvergleich von 3 × 75 mg Zotepin und 3 × 4 mg Haloperidol bei akut schizophrenen Patienten
1991
IX. The hereditary blood factors of the Yemenite and Kurdish Jews
1973
[Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
1991
Zur Behandlung perioperativer Ängste bei Mammakarzinomverdacht mit einem Phytotranquilizer
2000
Sergejewa, A. S.: Chemie des Holzes und der Cellulose. Dresden und Leipzig 1959: Th. Steinkopff. VIII + 143 S. Übersetzt von H. Schwarz, Oberförster a. D
1959
Effects of High and Low Dosage of Haloperidol on the Brain in Relation to Schizophrenic Thought Disorder
1984
[Does acupuncture influence the cardiac autonomic nervous system in patients with minor depression or anxiety disorders?].
2003
Acute Anterior Myelitis Complicating West Nile Fever
1979
Practicable and Valid Approach to Evaluate the Efficacy of Nootropic Drugs by Means of Rating Scales
1984
Wirkungsdifferenzen bei Hoch- und Standarddosierung von Fluphenazin-Decanoat in Abhängigkeit von Patienten- Merkmalen
1980
[Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].
1984
Differential improvements from haloperidol in two types of schizophrenics
1984
Efficacy of a special Kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin — A double-blind placebo-controlled study of four weeks treatment
1996
EXPERIMENTAL COMPARISON OF THE EFFICACY AND COMPATIBILITY OF CLOZAPINE AND RISPERIDONE IN ACUTE SCHIZOPHRENIA
1992